Background and Purpose-Carotid webs have been increasingly recognized as a cause of recurrent stroke, but evidence remains scarce. We aim to report the clinical outcomes and first series of carotid stenting in a cohort of patients with strokes from symptomatic carotid webs. Methods-Prospective and consecutive data of patients <65 years old with cryptogenic stroke admitted within September 2014 to May 2017. Carotid web was defined by a shelf-like/linear filling defect in the posterior internal carotid artery bulb by computed tomographic angiography. Results-Twenty-four patients were identified (91.6% strokes/8.4% transient ischemic attacks [TIAs]). Median age was 46 (41-59) years, 61% were female, and 75% were black. Median National Institutes of Health Stroke Scale score was 10.5 (3.0-16.0) and ASPECTS (Alberta Stroke Program Early CT Score) was 8 (7-8). There were no parenchymal hemorrhages, and 96% of patients were independent at 3 months. All webs caused <50% stenosis. In patients with bilateral webs (58%), median ipsilateral web length was larger than contralateral (3.1 [3.0-4.5] mm versus 2.6 [1.85-2.9] mm; P=0.01), respectively. Twenty-nine percent of patients had thrombus superimposed on the symptomatic carotid web. A recurrent stroke/TIA involving the territory of the previously symptomatic web occurred in 7 (32%; 6 strokes/1 TIA) patients: 3 <1 week, 2 <first year, and 3 >1 year of follow-up. Two recurrences occurred on dual antiplatelet therapy, 3 on antiplatelet monotherapy, 1 within 24 hours of thrombolysis, and 1 off antithrombotics. Median follow-up was 12. 
A carotid web is a shelf-like linear filling defect in the posterior aspect of the internal carotid artery bulb and thought to represent an intimal variant of fibromuscular dysplasia (FMD). 1, 2 It was originally reported in 1968 as a filling defect, 3 and subsequently described as web-like septum, 4 septal FMD, 5 atypical FMD, 6 pseudovalvular fold, 7 thrombotic carotid megabulb, 8 carotid-bulb atypical FMD, 9 carotid (bulb) diaphragms, 10 shelf, 11 spur. 9 This entity has been increasingly recognized as a cause of recurrent stroke, but evidence regarding its natural history and treatment remains scarce. 2, 9, 10 We aim to report the clinical outcomes and the first series of carotid stenting in a cohort of patients with strokes related to a carotid web.
Methods
Prospective and consecutive data were collected from patients presenting from September 2014 to May 2017 to a comprehensive stroke center and retrospectively reviewed. Patients were included if <65 years of age and with negative standard stroke work-up by Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria (patients with >1 potential etiology were excluded) and neck with computed tomographic angiogram. This study was approved by the local Institutional Review Board.
All images were evaluated by 2 fellowship-trained neurointerventionalists and included after consensus read. Carotid web was defined as a shelf-like/linear and smooth filling defect in the posterior aspect of the carotid bulb. Dual antiplatelet therapy was started unless the stroke was considered large or hemorrhagic changes observed. If stenting was performed, dual antiplatelet therapy was maintained for 3 months followed by monotherapy. Refer to the online-only Data Supplement for additional methodological details.
Continuous variables are reported as median (interquartile range). Categorical variables are reported as proportions. Betweengroup comparisons were made with Wilcoxon rank-sum with SPSS Statistics 22(IBM, Armonk, NY).
Results
Twenty-four patients were identified. Median age was 46 (41-59) years, 61% were female, and 75% were black. Vascular risk factors were relatively infrequent: hypertension (41%), hyperlipidemia (4%), atrial fibrillation (0%), diabetes mellitus (12%), and smoking (8%). Median low-density lipoprotein was 89 (77-130) mg/dL and hemoglobin A1c was 5.5% (5.2%-5.8%).
All patients were symptomatic at time of presentation with 21 (91.6%) strokes and 2 (8.4%) transient ischemic attacks (TIAs). All strokes were nonlacunar, embolic appearing. Median National Institutes of Health Stroke Scale score was 10.5 (3.0-16.0) and ASPECTS (Alberta Stroke Program Early CT Score) was 8 (7) (8) . Eleven patients (46%) received intravenous thrombolysis and 13 (52%) mechanical thrombectomy (33% undergoing both), and no parenchymal hemorrhages occurred. Excellent outcome (modified Rankin Scale score 0-1) was achieved in 19 (79%) and modified Rankin Scale score 0-2 in 23 (96%) at 90 days.
Carotid Web
Twenty-one (87%) patients underwent conventional angiograms, and contrast stagnation in the web's rostral aspect was common ( Figure 1 ). Median ipsilateral web length was 3.6 (3.0-4.2) mm and degree of stenosis 0% [0-0]%. Fourteen (58%) patients had contralateral webs, all less prominent than the symptomatic side (one individual had symmetrical lesions). In patients with contralateral webs, median ipsilateral web length was larger than the contralateral web length Seven (29%) patients had thrombus superimposed to the web: 5 at baseline (all resolved on follow-up imaging) and 2 at the time of recurrent stroke (both previously demonstrated to have a clear web; Figure 2) .
No patient was found to have classic/medial FMD changes in cervical arteries. Three patients had a small dot of calcification not directly adjacent to the carotid web, and all had wall thickness <2.2 mm.
Recurrent Strokes
Recurrence involving the previously symptomatic web territory was noted in 7 (29%; 6 strokes/1 TIA) patients: 3 <1 week, 2 <1 year, and 3 >1 year follow-up. Two recurrent events happened during dual antiplatelet therapy, 3 on antiplatelet monotherapy, 1 within 24 hours of thrombolysis, and 1 in a patient off antithrombotics. No strokes/TIAs involving other vascular territories were observed. Median clinical follow-up was 10.7 (6.5-18.0) months. Carotid web length was not statistically different between patients with and without recurrent ischemic events (P=0.576). Two patients had evidence of encephalomalacia from previous strokes involving the same territory of the presenting stroke.
Carotid Stenting
Sixteen (66%) patients were stented at a median 12.2 (7.0-18.7) days after last stroke. There were no periprocedural complications and no recurrent stroke/TIA during a median clinical follow-up of 4 (2.4-12.0) months poststent. Twelve (75%) patients had follow-up imaging at ≥3 months (6.5 [3.0-12.5] months), and no restenosis was observed. 
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Local data from the Get With The Guidelines (American Heart Association/American Stroke Association) was available from January 2016 to March 2017 to allow the determination of carotid web prevalence. Out of 64 patients <65 years old admitted with cryptogenic stroke in our center (excluding cases with >1 potential cause), 11 carotid web cases were diagnosed in the same period, leading to 17% prevalence.
Discussion
We demonstrate that carotid webs represent high-risk lesions with a high rate of stroke recurrence (29%) and seem to be safely and effectively treated by carotid artery stenting. Multiple series have reported recurrent events in young subjects with carotid webs. 5, 6, 8, 11 A study revealed a carotid web prevalence of 37% in strokes of undermined etiology in patients <55 years old (statistically higher than in matched controls). 10 Other recent reports demonstrated carotid webs in 9.4% of patients <60 years old 2 and in 21% ≤55 years old, 12 with anterior circulation cryptogenic strokes. These results are in line with the presented findings and provide robust evidence associating carotid webs with cryptogenic ischemic strokes in the young. The diagnosis of carotid webs has historically relied on conventional angiography, and the present study is the largest series of webs that underwent catheter-based angiography. We consistently observed contrast stagnation rostral to the bulb, with pooling of contrast persisting into the angiogram's venous phase. Computed tomographic angiogram, however, may be the best method for carotid web identification because it allows multiplane reconstructions, identification of superimposed thrombus, and evaluation of atherosclerotic changes.
The relatively common finding of superimposed thrombus along the rostral surface of the web is striking, corroborating the etiologic plausibility of webs causing blood flow stagnation, predisposing to thromboembolism. Our rate of 7 of 24 (29%) thrombosed ipsilateral webs is in line with 2 of 7 (28%) from a previous series. 13 A substantial percentage (58%) of patients had contralateral carotid webs, which compares favorably with the literature. 12 Of note, contralateral webs remained asymptomatic during the study period and were less conspicuous compared with the symptomatic side. The best treatment strategy for patients with carotid webs remains unclear. Medical therapy with antiplatelet monotherapy may be insufficient considering the previously documented 30% ischemic recurrence rate. 9 Our results similarly indicated a 29% recurrence rate. Considering that webs are composed of fibrotic tissue and that positive remodeling has never been reported, short-term dual antiplatelet therapy or anticoagulation followed by monotherapy may not be optimal because it may not decrease the risk of recurrent stroke in the long-term. Therefore, revascularization may constitute a viable option. Our findings indicate that stenting is technically straightforward, safe, and potentially effective in preventing recurrent strokes (Figure 3 ).
Although carotid webs have a distinct defined morphology/radiological appearance, this study is limited by the lack of pathological confirmation. The relatively static nature (lack of significant remodeling with medical therapy) may expose patients with webs to persistent risk, and the relatively short follow-up duration of the current study may underestimate risks of recurrence. Ideally, we would have quantified the delay of contrast washout at the lesion site; however, most angiographic acquisitions were not sufficiently long. Selection bias is possible because stroke patients were not systematically evaluated.
Conclusions
Carotid web is associated with high recurrent stroke/TIA risk, despite antithrombotic use, and is amenable to carotid stenting. Further studies are warranted. 
